Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient enrolled in phase II study of AR-201 for egg allergy

Aug. 22, 2019

MSH3 linked to somatic expansion and disease phenotype in Huntington's disease and DM1

Aug. 22, 2019

Targeting NuRD for derepression of fetal hemoglobin in hemoglobinopathies

Aug. 22, 2019

PDX model allows study of hepatitis B virus in hepatocellular carcinoma

Aug. 22, 2019

Anti-RSV agent ziresovir demonstrates promising preclinical profile

Aug. 22, 2019

First patient enrolled in observational study of children and adolescents with Dravet syndrome

Aug. 21, 2019

Mersana Therapeutics initiates expansion portion of phase I trial of XMT-1536

Aug. 21, 2019

Phase III NEPTUNE study does not meet primary endpoint in patients with high TMB

Aug. 21, 2019

New cyclin-dependent kinase 4/6 inhibitors identified at Beta Pharma

Aug. 21, 2019

ST Pharm presents new antivirals

Aug. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...